279 related articles for article (PubMed ID: 36843225)
21. [Clinical features of children and their family members with family clusters of SARS-CoV-2 Omicron variant infection in Shanghai, China: an analysis of 380 cases].
Bian XL; Guo Z; Zhang K; Li MC; Wu ZM; Jiang Q; Guo MM; Fan SN; Chen JJ; Hui L; Zheng F; Zhang JP
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1085-1091. PubMed ID: 36305107
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
[TBL] [Abstract][Full Text] [Related]
23. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
[TBL] [Abstract][Full Text] [Related]
24. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
JAMA Netw Open; 2020 Dec; 3(12):e2031756. PubMed ID: 33315116
[TBL] [Abstract][Full Text] [Related]
25. Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).
Muadchimkaew M; Siripongboonsitti T; Wongpatcharawarakul S; Boonsankaew C; Tawinprai K; Soonklang K; Mahanonda N
Int J Infect Dis; 2022 Nov; 124():190-198. PubMed ID: 36180032
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China.
Xu H; Li H; You H; Zhang P; Li N; Jiang N; Cao Y; Qin L; Qin G; Qu H; Wang H; Zou B; He X; Li D; Zhao H; Huang G; Li Y; Zhang H; Zhu L; Qiao H; Li H; Liu S; Gu L; Yin G; Hu Y; Xu S; Guo W; Wang N; Liu C; Gao P; Cao J; Zheng Y; Zhang K; Wang Y; Chen H; Zhang J; Mu D; Niu J
Emerg Microbes Infect; 2023 Dec; 12(1):2149935. PubMed ID: 36398721
[TBL] [Abstract][Full Text] [Related]
27. Incidence and Transmission of SARS-CoV-2 in US Child Care Centers After COVID-19 Vaccines.
Shope TR; Chedid K; Hashikawa AN; Martin ET; Sieber MA; Des Ruisseau G; Williams JV; Wheeler SE; Johnson M; Stiegler M; D'Agostino H; Balasubramani GK; Yahner KA; Wang-Erickson AF
JAMA Netw Open; 2023 Oct; 6(10):e2339355. PubMed ID: 37874566
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
Chang H; Zhang X; Su H; Cai J; Liu X; Li J; Wang Y; Zhang Z; Zhu M; Zhao L; Zhang S; Mei K; Zhang L; Wang X; Yan H; Luo L; Xu Z; Zeng M
Epidemiol Infect; 2023 May; 151():e81. PubMed ID: 37142552
[TBL] [Abstract][Full Text] [Related]
29. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
[TBL] [Abstract][Full Text] [Related]
30. Case clustering, contact stratification, and transmission heterogeneity of SARS-CoV-2 Omicron BA.5 variants in Urumqi, China: An observational study.
Lu Y; Guo Z; Zeng T; Sun S; Lu Y; Teng Z; Tian M; Wang J; Li S; Fan X; Luan Z; Wang W; Cai Y; Wang K; Zhao S
J Glob Health; 2023 May; 13():06018. PubMed ID: 37199483
[TBL] [Abstract][Full Text] [Related]
31. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study.
Tang L; Zhang Y; Wang F; Wu D; Qian ZH; Zhang R; Wang AB; Huang C; Wang H; Ye Y; Lu M; Wang C; Ma YT; Pan J; Li YF; Lv XY; An Z; Rodewald L; Wang XY; Shao YM; Wu ZY; Yin Z
BMJ Open; 2022 Nov; 12(11):e063919. PubMed ID: 36368753
[TBL] [Abstract][Full Text] [Related]
32. Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan.
Ogata T; Tanaka H; Tanaka E; Osaki N; Noguchi E; Osaki Y; Tono A; Wada K
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805724
[TBL] [Abstract][Full Text] [Related]
33. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
[TBL] [Abstract][Full Text] [Related]
34. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
35. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
36. Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China.
Yang P; Dang B; Kang W; Li X; Wang T; Li R; Peng M; Liu Y; Wang L; Cheng Y; Yu S; Wei M; Gao H; Kang W; Shang L
Front Public Health; 2023; 11():1107343. PubMed ID: 36960364
[TBL] [Abstract][Full Text] [Related]
37. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
Front Immunol; 2022; 13():940562. PubMed ID: 36091023
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.
Huang Z; Xu S; Liu J; Wu L; Qiu J; Wang N; Ren J; Li Z; Guo X; Tao F; Chen J; Lu D; Sun X; Wang W
BMC Med; 2022 Oct; 20(1):400. PubMed ID: 36266697
[TBL] [Abstract][Full Text] [Related]
39. Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection.
Zhu Z; Cai J; Tang Q; Mo YY; Deng T; Zhang X; Xu K; Wu B; Tang H; Zhang Z
BMC Pulm Med; 2023 May; 23(1):177. PubMed ID: 37217986
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
